Headache / Migraine News From Medical News Today

New Clinical Trial Guidelines For Migraine

Thu, 26 Jan 2012 00:00:00 PST

Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE...

The Effects On The Brain Of Magic Mushrooms

Tue, 24 Jan 2012 01:00:00 PST

Brain scans of people under the influence of the psilocybin, the active ingredient in magic mushrooms, have given scientists the most detailed picture to date of how psychedelic drugs work...

Migraine - The Enigma Of Trial Results

Tue, 10 Jan 2012 09:00:00 PST

In order to find out the effect of acupuncture compared with sham acupuncture in treating migraines, a team of investigators carried out a randomized controlled human trial. 480 individuals at 9 hospitals in China who experienced migraines for over one year, with two or three migraines in the 3 months prior to the investigation, were enrolled to participate in the study...

Difficulties In Treating Migraines Highlighted By Two Randomized Controlled Trials

Tue, 10 Jan 2012 03:00:00 PST

Acupuncture and sham acupuncture appear equally effective in treating migraines, according to a clinical trial published in CMAJ (Canadian Medical Association Journal). An international team of researchers conducted a randomized controlled trial to determine the effect of acupuncture compared with sham acupuncture in treating migraines in 480 patients at nine hospitals in China...

Headaches After Traumatic Brain Injury Highest In Adolescents And Girls

Wed, 07 Dec 2011 01:00:00 PST

More than half a million children in the U.S. sustain a traumatic brain injury (TBI) every year. Adults who suffer TBI often report headaches afterward, but little is known about how often children suffer headaches after similar injuries...

Painful Migraines Linked To Higher Depression Risk

Sat, 26 Nov 2011 00:00:00 PST

Individuals who have migraines have a higher chance of experiencing major depressive episodes, researchers from the University of Calgary, Canada, reported in the journal Headache. The authors added that the higher risk is there the other way round - that those with major depressive episodes are also at a higher risk of having migraines...

Headaches Take Toll On Soldiers

Fri, 14 Oct 2011 01:00:00 PST

Headaches, a virtually universal human complaint at one time or another, are among the top reasons for medical evacuation of military personnel from Iraq and Afghanistan, and for ongoing depletion of active-duty ranks in those countries, according to research led by Johns Hopkins specialists...

Looking For A Link Between Seizures And Migraine In Soldiers With TBI

Thu, 13 Oct 2011 01:00:00 PST

Traumatic brain injury (TBI) affects many Americans: high school athletes, drivers and passengers in motor vehicle accidents, and victims of domestic violence, to name a few. Some of the most striking effects of brain injury are seen in our soldiers and veterans returning from Iraq and Afghanistan...

Exercise Just As Good As Drugs At Preventing Migraines

Tue, 11 Oct 2011 00:00:00 PST

Although exercise is often prescribed as a treatment for migraine, there has not previously been sufficient scientific evidence that it really works. However, research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, has now shown that exercise is just as good as drugs at preventing migraines...

Europe May Have Less Headaches: New Neuro Migraine Device Approved

Thu, 08 Sep 2011 02:00:00 PST

In a move that the US Food and Drug Administration (FDA) turned down earlier this year based on a lack of evidence that it actually works, St. Jude Medical has won European CE regulatory approval for the use of its implanted neurostimulation device for patients with severe chronic migraine headaches...

St. Jude Medical Announces European Regulatory Approval Of First Implanted Neurostimulation Device To Treat Chronic Migraine

Thu, 08 Sep 2011 02:00:00 PST

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced it has received the industry's first and only regulatory approval for the use of an implanted neurostimulation device for patients with intractable chronic migraine...

Cluster Headache - It's Nice When It Stops

Thu, 25 Aug 2011 00:00:00 PST

Cluster headache has a substantial detrimental effect on quality of life. New invasive procedures, such as hypothalamic deep brain stimulation and bilateral occipital nerve stimulation, may help patients with chronic refractory headache...

CoLucid Pharmaceuticals Receives Clearance For Investigational New Drug (IND) Application For Lasmiditan For The Treatment Of Acute Migraine

Fri, 19 Aug 2011 02:00:00 PST

CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced that it has received clearance to proceed with clinical studies of lasmiditan (formerly known as COL-144) under IND 103,420 from the Food and Drug Administration (FDA)...

Headaches Are Common In Year Following Traumatic Brain Injury, Especially Among Females

Fri, 19 Aug 2011 01:00:00 PST

Recurring headaches are common during the year following a traumatic brain injury (TBI), regardless of the severity of the TBI, and they tend to occur more often among females and those with a pre-TBI history of headache, according to an article in Journal of Neurotrauma, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is available free online at the link below...

Multiple Migraine Attacks - Promising Results For SUMAVEL DosePro Phase 4 Clinical Trial

Sat, 06 Aug 2011 09:00:00 PST

The publication of SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery system Phase 4 clinical study results were announced by Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. SAMUVEL was found to be an important treatment option for those with rapid-onset migraine attacks...

Tylenol Maximum Daily Dosage To Drop To 3,000mg Per Day From 4,000mg

Thu, 28 Jul 2011 14:00:00 PST

Tylenol, whose active ingredient is acetaminophen, will now have a lower recommended daily dose, which is aimed at reducing the risk of accidental overdose, McNeil Consumer Healthcare, a Johnson & Johnson company announced today. The recommended daily maximum for Extra Strength Tylenol 500mg tablets will go down from 8 per day to 6 per day, i.e. from 4,000mg per day to 3,000mg per day...

New Study Finds Images Placed In Front Of Smartphone Screen Increase Visual Discomfort

Sun, 24 Jul 2011 00:00:00 PST

Several reports indicate that prolonged viewing of mobile devices and other stereo 3D devices leads to visual discomfort, fatigue and even headaches. According to a new Journal of Vision study, the root cause may be the demand on our eyes to focus on the screen and simultaneously adjust to the distance of the content...

Behavioral Treatment For Migraines A Cost-Effective Alternative To Meds

Wed, 06 Jul 2011 04:00:00 PST

Treating chronic migraines with behavioral approaches - such as relaxation training, hypnosis and biofeedback - can make financial sense compared to prescription-drug treatment, especially after a year or more, a new study found. Longtime behavioral therapy researcher and practitioner Dr. Donald Penzien, University of Mississippi Medical Center professor of psychiatry, coauthored the study...

Common Forms Of Neck Pain Not Cured By Botulinum Toxin

Wed, 06 Jul 2011 03:00:00 PST

There is no evidence that Botulinum toxin injections reduce chronic neck pain or associated headaches, says a group of scientists who reviewed nine trials involving a total of 503 participants. Their findings are published in the latest update of The Cochrane Library. The Botulinum toxin (BoNT) operates by temporarily stopping muscles contracting. This reduces muscle tightness or spasm...

Autonomic Technologies Announces Positive Preliminary Findings For A Novel Device For The Treatment Of Severe Headache

Mon, 27 Jun 2011 05:00:00 PST

Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable system for severe headaches, today announced positive preliminary findings from a study evaluating the safety and efficacy of the company's investigational neurostimulation system for the treatment of cluster headache. Jean Schoenen, M.D...

New Migraine Neurostimulation Treatment On The US Horizon?

Fri, 24 Jun 2011 09:00:00 PST

St. Jude Medical says it is seeking European regulatory permission to sell a device that somewhat alleviates migraine headaches. Yes, "somewhat" as initial testing has fallen short of the FDA's overall goals, but even so, a quarter of the group experienced a decrease in headaches. The future of the device in the U.S...

The First Animal Model Of A Severe Form Of Migraine Indicates Increased Neuronal Excitability As A Possible Cause

Thu, 23 Jun 2011 14:00:00 PST

Familial hemiplegic migraine is a rare and severe subtype of migraine with aura, an unusual sensory experience preceding the migraine attack. Researchers from the San Raffaele Scientific Institute in Milan, and CNR Institute of Neuroscience in Pisa, Italy, have developed a mouse model of Familial Hemiplegic Migraine type 2 (FHM2) and used it to investigate the migraine's cause...

St. Jude Medical Reveals Randomized Clinical Trial Data Demonstrating Benefit Of Neuromodulation For Chronic Migraine

Thu, 23 Jun 2011 03:00:00 PST

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide...

Clinical Trial Data Demonstrating Benefit Of Neuromodulation For Chronic Migraine

Thu, 23 Jun 2011 03:00:00 PST

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide...

Migraine Relief From Bariatric Surgery For Morbidly Obese Individuals

Sun, 19 Jun 2011 00:00:00 PST

90% of morbidly obese patients who suffered from migraines and underwent bariatric surgery achieved partial or total relief of their condition, researchers from the University of Iowa revealed at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS)...

Comments (0) - Read and Add your own Comments